clinical implications of her2 in gi cancers
Published 3 years ago • 130 plays • Length 2:59Download video MP4
Download video MP3
Similar videos
-
0:32
adverse effects of ramucirumab plus paclitaxel for her2- g/gej cancer
-
2:19
asco gi 2021: her2-positive gastric cancer, polo and key trials in progress
-
16:38
the her-2 pathway in gi cancer
-
10:08
evolving role of her2 targeted therapies in gastroesophageal cancers
-
1:01
new combination therapies in her2-expressing gastric cancer
-
2:38
her2 in gastric cancer
-
3:12
advances in her2-targeted therapies for gastric cancer
-
1:08
the role of neoadjuvant immunotherapy in msi-high gastric cancer
-
0:59
the significance of her2 expression for the activity of trastuzumab deruxtecan
-
3:24
her2 testing in gastroesophageal cancers
-
8:17
metastatic gastric cancer: indications and impact of targeting the her2 pathway?
-
2:39
first line immunotherapy/chemotherapy in her2- gastric cancer in japan
-
1:37
consolidative radiotherapy for oligometastatic her2-negative esophageal and gastric adenocarcinoma.
-
1:32
safety concerns of using her2-targeting therapies in gastrointestinal cancers
-
4:41
destiny-gastric03: trastuzumab deruxtecan in her2-overexpressing gastric cancer
-
1:34
destiny-gastric03: t-dxd in her2 and her2-low gastric cancer
-
4:01
the role of immunotherapy in gastrointestinal cancers: an update from esmo
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer
-
4:39
latest news in gastric cancer from asco gi